Navigation Links
New Study on Cordyceps Sinensis (Hirsutella Sinensis) Shows Anti-Inflammatory Properties
Date:4/30/2013

Los Angeles, CA (PRWEB) April 30, 2013

Cordyceps sinensis is a medicinal fungus used for centuries in Asian countries as a health supplement and tonic. Traditionally prescribed by medical practitioners as a kidney and lung supplement, studies have found Cordyceps Sinensis’ impact on the human body reaches other functions as well, such as energy, fertility and anti-inflammation.*

Published in the March 5, 2013 issue of Scientific Journal, a new study details findings revealing Cordyceps Sinensis’ anti-inflammatory properties. These benefits were attributed to Cordyceps Sinensis’ ability to inhibit both canonical and non-canonical inflammasomes. Inflammasomes have been associated with several auto-inflammatory conditions such as gout. This study, performed at the Center for Molecular and Clinical Immunology at Chang Gung University in Taiwan, documents Cordyceps Sinensis’ suppression of interleukin-1ß and interleukin-18 secretion.

The study uses a specific anamorphic mycelial form of Cordyceps Sinensis known as Hirsutella Sinensis. This specific strain has proven to be rare and difficult to cultivate. Through Molecular Germplasm Identification, this particular strain of Cordyceps Sinensis' rDNA sequence matches wild-grown Cordyceps Sinensis by 99.645%, proving authenticity. Other strains on the market match only by 82.791%.

Download Cordyceps Sinensis (Hirsutella Sinensis) Clinical Trial

How to cite the study: Huang, T. et al. Hirsutella sinensis mycelium suppresses interleukin-1b and interleukin-18 secretion by inhibiting both canonical and non-canonical inflammasomes. Sci. Rep. 3, 1374; DOI:10.1038/srep01374 (2013).

*Legal Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Read the full story at http://www.prweb.com/releases/cordyceps-sinensis/hirstuella-sinensis/prweb10684567.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
2. Wysebridge Patent Bar Review Launches America Invents Act (AIA) Study Suite
3. Breath study brings roadside drug testing closer
4. Japan Bioinformatics Announces Release of a Case Study on Detecting SNPs and Short INDELs
5. Research Foundations Collaborate To Fund Phase 1 Study Of Cancer Drug In Alzheimers Disease Patients
6. Ceregene Reports Data From Parkinsons Disease Phase 2b Study
7. Study Says Kidney Bean Leaves Work Against Bed Bugs, My Cleaning Products Compares Its With a Non-Pesticide Bed Bug Spray
8. NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinsons Disease
9. A bright idea: Tiny injectable LEDs help neuroscientists study the brain
10. Study Says Bed Bugs Show Resistance to Pesticides, My Cleaning Products Asserts Non-Pesticide Bed Bug Bully Is the Better Pick Against the Pests
11. Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... its latest innovations on its free and validated Electronic Data Capture (EDC) system ... the Outsourcing in Clinical Trials West Coast 2016 Conference in San Mateo, California ...
(Date:2/9/2016)... , Feb. 9, 2016  DNAtrix, a ... for cancer, announced that its lead product, ... Commission as an orphan medicinal product for ... form of glioma, strikes approximately 25,000 people ... http://photos.prnewswire.com/prnh/20160208/330986LOGO --> ...
(Date:2/9/2016)... 9, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
(Date:2/8/2016)... 2016 Novan, Inc. today announced that Director Robert ... Directors of Novan. In addition, Robert Keegan has been ... Carolina . --> North Carolina ... received a total of $32.8 million of net proceeds in a ... network originating throughout the Research Triangle area of North ...
Breaking Biology Technology:
(Date:1/25/2016)... -- Glencoe Software, the world-leading supplier of image data management ... the data management solution OMERO Plus for the newly ... Photo - http://photos.prnewswire.com/prnh/20160125/325328LOGO ... Phenotypic analysis measures the characteristics and behavior of cells, ... such as health and disease, the presence or absence ...
(Date:1/20/2016)... , Jan. 20, 2016 A market that ... directly benefit from the explosion in genomics knowledge. Learn ... Sound Research. A range of dynamic trends are pushing ... - personalized medicine - pharmacogenomics - pathogen evolution - ... large markets - greater understanding of the role of ...
(Date:1/15/2016)... , Jan. 15, 2016 Recent publicized ... small to find new ways to ensure data security ... iOS and Android that ties ... biometrics, transforming it into a hardware authorization token. Customer ... swipe their fingerprint on their KodeKey enabled device to ...
Breaking Biology News(10 mins):